Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues

Cancer Biology and Therapy

Volumn 8, Issue 10, 2009, Pages 907-916

  Ma, Changqing ^a   Quesnelle, Kelly M ^a,d   Sparano, Anthony ^a   Rao, Shilpa ^a   Park, Min S ^a,e   Cohen, Marc A ^a   Wang, Yan ^b   Samanta, Minu ^a   Kumar, Madhu S ^c   Aziz, M Usman ^a   Naylor, Tara L ^a,f   Weber, Barbara L ^b   Fakharzadeh, Steven S ^a   Weinstein, Gregory S ^a   Vachani, Anil ^a   Feldman, Michael D ^a   Brose, Marcia S ^a,g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GLAXOSMITHKLINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f NOVARTIS   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; CSMD1; Epithelial cancers; Head and neck cancer; Lung cancer; Squamous cell carcinoma; Tumor suppressor genes

Indexed keywords

CUB AND SUSHI MULTIPLE DOMAIN 1 PROTEIN; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CUB AND SUSHI MULTIPLE DOMAIN 1; DIFFERENTIAL DIAGNOSIS; EXON; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; HEAD AND NECK CARCINOMA; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TUMOR; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; FEMALE; GENE DOSAGE; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MEMBRANE PROTEINS; MOUTH NEOPLASMS; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 68049139551     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.10.8132     Document Type: Article

References (25)

1. Ries LAG EM, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, et al. SEER Cancer Statistics Review, 1975-2000, National Cancer Institute. Bethesda MD 2003.
2. Sun PC, Uppaluri R, Schmidt AP, Pashia ME, Quant EC, Sunwoo JB, et al. Transcript map of the 8p23 putative tumor suppressor region. Genomics 2001; 75:17.
3. Kraus DM, Elliott GS, Chute H, Horan T, Pfenninger KH, Sanford SD, et al. CSMD1 Is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol 2006; 176:4419-30.
4. Shimizu A, Asakawa S, Sasaki T, Yamazaki S, Yamagata H, Kudoh J, et al. A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1. Biochem Biophys Res Commun 2003; 309:143.
5. Lau WL, Scholnick SB. Identification of two new members of the CSMD gene family. Genomics 2003; 82:412.
6. Miwa T, Song W-C. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int Immunopharmacol 2001; 1:445.
7. Farrell C, Crimm H, Meeh P, Croshaw R, Barbar T, Vandersteenhoven JJ, et al. Somatic mutations to CSMD1 in colorectal adenocarcinomas. Cancer Biol Ther 2008; 7:609-13.
8. Toomes C, Jackson A, Maguire K, Wood J, Gollin S, Ishwad C, et al. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer 2003; 37:132-40.
9. Richter T, Tong B, Scholnick S. Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines. Cancer Cell Int 2005; 5:29.
10. Sunwoo JB, Sun PC, Gupta VK, Schmidt AP, El-Mofty S, Scholnick SB. Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene 1999; 18:2651-5.
11. Sun PC, Schmidt AP, Pashia ME, Sunwoo JB, Scholnick SB. Homozygous Deletions define a region of 8p23.2 containing a putative tumor suppressor gene. Genomics 1999; 62:184.
12. Ishwad CS, Shuster M, Bockmühl U, Thakker N, Shah P, Toomes C, et al. Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer. Int J Cancer 1999; 80:25-31.
13. Bockmuhl U, Ishwad CS, Ferrell RE, Gollin SM. Association of 8p23 deletions with poor survival in head and neck cancer. Otolaryngol Head Neck Surg 2001; 124:451.
14. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 2005; 65:7561-7.
15. Wright K, Wilson PJ, Kerr J, Do K, Hurst T, Khoo SK, et al. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas. Oncogene 1998; 17:1185-8.
16. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, et al. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 2005; 11:7012-22.
17. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 2004; 13:1303-13.
18. Henshall SM, Afar DEH, Hiller J, Horvath LG, Quinn DI, Rasiah KK, et al. Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res 2003; 63:4196-203.
19. Sparano AMD, Quesnelle KM, Kumar MS, Wang YMD, Sylvester AJ, Feldman MMDP, et al. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 2006; 116:735-41.
20. Greshock J, Naylor TL, Margolin A, Diskin S, Cleaver SH, Futreal PA, et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 2004; 14:179-87.
21. Naylor T, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 2005; 7:1186-98.
22. Margolin AA, Greshock J, Naylor TL, Mosse Y, Maris JM, Bignell G, et al. CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number data. Bioinformatics 2005; 21:3308-11.
23. Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004; 313:856.
24. Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-rime PCR. Hum Mutat 2003; 22:476-85.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT Method. Methods 2001; 25:402.